Souhaitez-vous accéder aux communiqués récents ?

Dublin, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The "Competitive Landscape of the Clinical Trials Market, Including Company Strategies, Sustainability Benchmarking, Key Player Developments, and Revenue...

Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Gastroesophageal (GE) Junction Carcinomas - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's...

Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Epidermolysis Bullosa - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...

Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Gastroenteritis - Global Clinical Trials Review, 2025" has been added to ResearchAndMarkets.com's offering. The clinical trial report offers a...

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "Encephalitis - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides top line...

Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1Remibrutinib, a highly selective oral BTK inhibitor, was...

In ALIGN study, Vanrafia (atrasentan) showed positive difference in eGFR change from baseline vs. placebo at Week 136, 4 weeks after study treatment ended1Results favored Vanrafia across multiple...

MALVERN, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral...

Hepatitis B Treatment Market to reach USD 7.74B by 2033, driven by rising chronic cases, antiviral innovation, and expanding global screening programs.

NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, continues to accelerate clinical trial...